TFFP: TFF Pharma Company Value to Net Income

Corporate emblem and logo of TFF Pharmaceuticals Inc. (TFFP)

This chart reflects that the asset value of TFF Pharmaceuticals (TFFP) is fixed at 0.00, while the business develops inhalation products to minimize syringe use for environmental protection. The company's revenues are based on licensing payments for its drug sublimation method from industry behemoths. However, due to a capital shortage, the enterprise went bankrupt, transferring all patents to the pledgees and ceasing operations.

TFFP TFF Pharmaceuticals, Inc: Price to Earnings Ratio in the range 07/04/2022 - 12/21/2024

Comprehensive metric breakdowns and analytics for TFF Pharma (TFFP)

- price and consensus price forecast:
Stock Price tffpharma.com|TFFP - Consensus Target
- market capitalization information:
Market Value TFF Pharmaceuticals, Inc.|TFFP - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share TFF Pharmaceuticals|TFFP - Company Net Assets|Market Cap to Book Value Multiple tffpharma.com|TFFP - Company Total Assets
- company liabilities and liquidity data:
All Debt to Shareholders' Equity Ratio TFF Pharmaceuticals|TFFP - Long-Term Debt to Capital|Current Liabilities to Capital TFF Pharmaceuticals, Inc|TFFP - Company Debts|Debt to Net Assets Ratio TFF Pharmaceuticals, Inc.|TFFP - Company Long-Term Liabilities|Amount of Current Liabilities TFF Pharmaceuticals|Critical Liquidity Ratio tffpharma.com
- business earnings and investment ratios data:
TFFP - Net Profit|Forward Earnings TFF Pharmaceuticals|TFFP - Price to Earnings Ratio|Future Price to Earnings Multiple TFF Pharmaceuticals Inc.|TFFP - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio TFF Pharmaceuticals, Inc.|TFFP - Operating profit EBITDA|Earnings per share for the trailing year TFF Pharmaceuticals|TFFP - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth tffpharma.com|TFFP - Earnings per share growth in current year|Expected earnings per share trend next year TFF Pharmaceuticals
Comprehensive company analysis:tffpharma.com - TFFP
Flagship merchandise of TFF Pharmaceuticals, Inc.

The P/E ratio reflects the market value of a single unit of the business's net profit. This ratio is calculated as the relationship between market capitalization and earnings, demonstrating the degree of investor optimism regarding future growth rates. By analyzing the calculated price-to-earnings multiple, one can identify the time lag between the company's actual achievements and the price action. For TFF Pharmaceuticals (TFFP), this indicator is sensitive to R&D center results and progress in developing unique drug stabilization methods.

Competing companies

P/E Multiple haleon.com|Price to Earnings Ratio KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Company Value to Net Income|Price to Earnings Ratio Jyong Biotech Corp MENS|Ligand Corp (LGND) - Market Cap to Earnings|AMRX: Price to Earnings Ratio|perrigo.com - Market Price to Net Income Ratio|ALVO: P/E Multiple|Liquidia Corp - Company Value to Net Income|GLPG (Galapagos Genomics) - P/E Multiple|Market Cap to Earnings ANI Pharmaceuticals Corp ANIP|Price to Earnings Ratio MannKind Corporation (MNKD)|AMPH (amphastar.com) - Company Value to Net Income|Pacira BioSciences, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio SPRY (ARS Pharmaceuticals Inc)|Theravance - P/E Multiple|Market Cap to Net Income AQST|SCPH: P/E Multiple|Market Cap to Net Income TECX (Tectonic Therapeutic)|Price to Earnings Ratio TNXP|SXTC: Company Value to Net Income|Price to Earnings Ratio Eupraxia Pharmaceuticals (EPRX)|BHST: Market Cap to Net Income|P/E Multiple EXOZ (eXoZymes Inc)|Company Value to Net Income ORMP|Entera Bio Corp - P/E Multiple|HYFT - P/E Multiple|ABVC BioPharma Inc (ABVC) - Price to Earnings Ratio|Cumberland Corp - Company Value to Net Income|Price to Earnings Ratio Quantum BioPharma Ltd|Price to Earnings Ratio fibrogen.com (FGEN)|P/E Multiple TELO|P/E Multiple ranitherapeutics.com (RANI)|P/E Multiple SNYR (Synergy CHC)|RLYB - Price to Earnings Ratio|Lexaria - P/E Multiple|Market Cap to Earnings pulmatrix.com|PTHL (ftzy.com.cn) - Price to Earnings Ratio|Aptorum Group (APM) - P/E Multiple|Price to Earnings Ratio LYRA|IBO (Impact BioMedical, Inc.) - Market Price to Net Income Ratio|P/E Multiple TNFA|Business Payback Period cbdmd.com|P/E Multiple PRFX (PainReform)|CYTO - Price to Earnings Ratio|Lipella - P/E Multiple|OPTN - P/E Multiple|Pieris Pharmaceuticals (PIRS) - Price to Earnings Ratio|PROC (procapsgroup.com) - Price to Earnings Ratio|Price to Earnings Ratio Petros Pharmaceuticals, Inc.|Qilian International Holding Group (QLI) - Business Payback Period|Price to Earnings Ratio SLRN (ACELYRIN, Inc.)